High Nrf2 expression correlates with low survival rates in melanoma patients by triggering infinite cell growth and proliferation, reduced apoptotic death, enhanced chemoresistance and radioresistance, and induced both angiogenesis and metastasis in these tumours [34,45,46]. Here, NFE2L2 is linked to neoplasm.